Go ahead for new treatment for Black Bone Disease
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
LJMU is part of a consortium aiming to improve digital connectivity in high density settings.
LJMU collaborates to accelerate real world benefits from laboratories
Gebrasale 'honoured' to be part of sport science research study
With awareness campaigns World Stroke Day later this month (29 October), we're shining a spotlight on one of LJMU’s latest research projects; TARGET, which is developing cutting edge AI technology to track and prevent strokes and atrial fibrillation.
New research suggests blue eyed humans better than brown eyed in seeing in dark
Experts explain how to better manage regional resources
Research shows that far from choosing safe and familiar locations, holidaymakers prefer places they know little about.
Pharmacists-to-be are being trained on the world's first fully patient-controlled online health record.
National speakers at event on September 29